PWP
BIO icon

Private Wealth Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Private Wealth Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,500
Closed -$1.63M – 119
2018
Q1 		$1.63M Buy
+6,500
New +$1.66M 0.28% 63

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Private Wealth Partners's BIO Position: Q2 2018 in Review

Private Wealth Partners sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2018, closing a stake of 6,500 shares — an estimated $1.63M sold.

Private Wealth Partners first reported a position in BIO in Q1 2018 and held it in 1 quarter. The position peaked at $1.63M in Q1 2018. 326 funds tracked by Wall St. Rank hold BIO as of Q2 2018.

  • Private Wealth Partners reported no remaining Bio-Rad Laboratories Class A position as of Q2 2018 after selling out during the quarter.
  • Private Wealth Partners sold 6,500 Bio-Rad Laboratories Class A shares in Q2 2018, an estimated $1.63M.
  • Private Wealth Partners first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and held it in 1 quarter.
  • Private Wealth Partners's Bio-Rad Laboratories Class A position peaked at $1.63M in Q1 2018.
  • 326 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2018.

Based on Private Wealth Partners's 13F filing for Q2 2018, filed 10 Aug 2018.